SR 42
- Session Year: 2025-2026
- House: Senate
- Latest Version Date: 2025-05-29
Current Status:
In Progress
(2025-05-27: Read. Adopted. (Ayes 39. Noes 0. Page 1247.))
Introduced
In Committee
Awaiting First Chamber Vote
Passed First Chamber
In Committee
Awaiting Second Chamber Vote
Passed Second Chamber
Enacted
WHEREAS, Amyotrophic lateral sclerosis (ALS), also commonly known as Lou Gehrigs disease, is a progressive fatal neurodegenerative disease in which a persons brain loses connection with their muscles, slowly reducing a persons ability to walk, talk, eat, and eventually breathe; and
WHEREAS, Thousands of new ALS cases are reported every year, and estimates show that every 90 minutes someone is diagnosed with ALS and someone passes away from ALS; and
WHEREAS, On average, patients diagnosed with ALS survive only two to five years from the time of diagnosis; and
WHEREAS, The exact causes of ALS are unknown and there is no known cure for ALS; and
WHEREAS, People who have served in the military are more likely to develop ALS and die from the disease than those with no history of military service; and
WHEREAS, Securing access to new therapies, durable medical equipment, and communication technologies is of vital importance to people living with ALS; and
WHEREAS, Clinical trials play a pivotal role in evaluating new treatments, enhancing quality of life, and fostering assistive technologies for those living with ALS; and
WHEREAS, The ALS Association is the largest philanthropic funder of ALS research globally and has committed more than $154,000,000 to support more than 550 projects across the United States and 18 other countries; and
WHEREAS, The ALS Association is committed to accelerating the pace of discovery, fueled by the hope that one day ALS will be a livable disease for everyone, everywhere, until a cure can be found; and
WHEREAS, Amyotrophic Lateral Sclerosis Awareness Month provides an opportunity to increase public awareness of the dire circumstances of people living with ALS, acknowledge the terrible impact this disease has on those individuals and their families, and support research to eradicate this disease; now, therefore, be it
Resolved by the Senate of the State of California, That the Senate hereby proclaims the month of May 2025 as Amyotrophic Lateral Sclerosis Awareness Month, and calls upon all Americans to join in supporting ALS research, advocating for increased funding, and standing in solidarity with those affected by this relentless disease; and be it further
Resolved, That the Secretary of the Senate transmit copies of this resolution to the author for appropriate distribution.
WHEREAS, Amyotrophic lateral sclerosis (ALS), also commonly known as Lou Gehrigs disease, is a progressive fatal neurodegenerative disease in which a persons brain loses connection with their muscles, slowly reducing a persons ability to walk, talk, eat, and eventually breathe; and
WHEREAS, Thousands of new ALS cases are reported every year, and estimates show that every 90 minutes someone is diagnosed with ALS and someone passes away from ALS; and
WHEREAS, On average, patients diagnosed with ALS survive only two to five years from the time of diagnosis; and
WHEREAS, The exact causes of ALS are unknown and there is no known cure for ALS; and
WHEREAS, People who have served in the military are more likely to develop ALS and die from the disease than those with no history of military service; and
WHEREAS, Securing access to new therapies, durable medical equipment, and communication technologies is of vital importance to people living with ALS; and
WHEREAS, Clinical trials play a pivotal role in evaluating new treatments, enhancing quality of life, and fostering assistive technologies for those living with ALS; and
WHEREAS, The ALS Association is the largest philanthropic funder of ALS research globally and has committed more than $154,000,000 to support more than 550 projects across the United States and 18 other countries; and
WHEREAS, The ALS Association is committed to accelerating the pace of discovery, fueled by the hope that one day ALS will be a livable disease for everyone, everywhere, until a cure can be found; and
WHEREAS, Amyotrophic Lateral Sclerosis Awareness Month provides an opportunity to increase public awareness of the dire circumstances of people living with ALS, acknowledge the terrible impact this disease has on those individuals and their families, and support research to eradicate this disease; now, therefore, be it
Resolved by the Senate of the State of California, That the Senate hereby proclaims the month of May 2025 as Amyotrophic Lateral Sclerosis Awareness Month, and calls upon all Americans to join in supporting ALS research, advocating for increased funding, and standing in solidarity with those affected by this relentless disease; and be it further
Resolved, That the Secretary of the Senate transmit copies of this resolution to the author for appropriate distribution.
|
Date
|
Status
|
|---|---|
| May 27, 2025 | Read. Adopted. (Ayes 39. Noes 0. Page 1247.) |
| May 21, 2025 | From committee: Ordered to third reading. |
| May 8, 2025 | Introduced. Referred to Com. on RLS. |
|
Date
|
Description
|
Location
|
Votes
|
|
|---|---|---|---|---|
| May 27, 2025 | Senate 3rd Reading SR42 Choi et al. | Senate Floor |
Passed |
This list shows positions taken on this bill by organizations on the date displayed, which is linked to the original source.
Positions by individuals are not included.
SENATE RULES COMMITTEE Office of Senate Floor Analyses (916) 651-1520 Fax: (916) 327-4478 | SR 42 |
THIRD READING
Bill No: SR 42
Author: Choi (R), et al.
Introduced: 5/8/25
Vote: Majority
SUBJECT: Amyotrophic Lateral Sclerosis Awareness Month
SOURCE: Author
DIGEST:
This resolution proclaims the month of May 2025 as Amyotrophic Lateral Sclerosis Awareness Month, and calls upon all Americans to join in supporting ALS research, advocating for increased funding, and standing in solidarity with those affected by this relentless disease.
ANALYSIS: This resolution makes the following legislative findings:
- Amyotrophic lateral sclerosis (ALS), also commonly known as Lou Gehrig’s disease, is a progressive fatal neurodegenerative disease in which a person’s brain loses connection with their muscles, slowly reducing a person’s ability to walk, talk, eat, and eventually breathe.
- On average, patients diagnosed with ALS survive only two to five years from the time of diagnosis. The exact causes of ALS are unknown and there is no known cure for ALS.
- People who have served in the military are more likely to develop ALS and die from the disease than those with no history of military service.
- The ALS Association is the largest philanthropic funder of ALS research globally and has committed more than $154 million to support more than 550 projects across the United States and 18 other countries.
This resolution proclaims the month of May 2025 as Amyotrophic Lateral Sclerosis Awareness Month, and calls upon all Americans to join in supporting ALS research, advocating for increased funding, and standing in solidarity with those affected by this relentless disease.
Related/Prior Legislation
ACR 190 (Dixon, Resolution Chapter 102, Statutes of 2024).
FISCAL EFFECT: Appropriation: No Fiscal Com.: No Local: No
SUPPORT: (Verified 5/20/25)
None received
OPPOSITION: (Verified 5/20/25)
None received
Prepared by: Sofia Pachon-Mendez / SFA / (916) 651-1520
5/21/25 15:50:33
**** END ****
Bill Author
Bill Co-Author(s):